The main purpose of the research study is to estimate the prevalence of tobacco product use and describe the tobacco use patterns in adults in Italy.
The aim of the survey is to describe the current and past patterns of use of tobacco products in the general adult population of Italy and in adult IQOS users registered in the IQOS user database of Philip Morris Italia S.r.l. (Italy IQOS User Database), and explore their association with key independent variables. More specifically, the objectives are: 1. Estimate the prevalence of current tobacco use status in the study population. 2. Describe the past tobacco use status (cigarette, IQOS and other innovative products, including e-cigarettes) in the study population (i.e. never-use, initiation, product use transition, cessation, re-initiation, and relapse). 3. Explore the association between self-reported health status and use of tobacco products in the study population. 4. Explore the association between patterns of use (including misuse) with motivation to use, perceived quality attributes of IQOS (e.g. risk and self-reported changes since switching to the product, in a number of relevant domains where IQOS may have potential benefits), and consumer's satisfaction in the population of IQOS users in Italy registered in the Italy IQOS User Database.
Study Type
OBSERVATIONAL
Enrollment
6,107
Face-to-face survey to estimate the prevalence of current tobacco use status in the general population of Italy.
Online survey to describe patterns of use in IQOS users residing in Italy.
Philip Morris Products S.A.
Lausanne, Switzerland
Prevalence of current tobacco use
Prevalence of current tobacco use status in the study population.
Time frame: Study duration (3 years).
Past tobacco use status
Past tobacco use status (cigarette, IQOS and other innovative products) in the study population.
Time frame: Study duration (3 years).
Self-reported health status
Association between self-reported health status and use of tobacco products in the study population.
Time frame: Study duration (3 years).
Perceived risk
Association between patterns of use with perceived risk.
Time frame: Study duration (3 years).
IQOS use experience
Describe the IQOS user experience, including motivation to use, mis-use, satisfaction, and self-reported changes since switching to the product (in a number of relevant domains where IQOS may have potential benefits).
Time frame: Study duration (3 years).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.